Adaptimmune Therapeutics
ADAP
$1.19
Share price
-1.65%
Change (1 day)
-13.14%
Change (1 year)
Categories
Number of shares outstanding for Adaptimmune Therapeutics (ADAP)
Number of shares outstanding as of May 2024 : 226,308,276
According to Adaptimmune Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 226,308,276. At the end of 2023 the company had 226,308,276 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Adaptimmune Therapeutics from 2014 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.22 B | 37.89% |
| 2022 | 0.16 B | 5.06% |
| 2021 | 0.15 B | 0.93% |
| 2020 | 0.15 B | 47.18% |
| 2019 | 0.10 B | 0.57% |
| 2018 | 0.10 B | 11.62% |
| 2017 | 93.68 M | 32.35% |
| 2016 | 70.78 M | 0% |
| 2015 | 70.78 M | -83.33% |
| 2014 | 0.42 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 uniQure QURE | 47,770,101 | -78.89% | 🇳🇱 Netherlands |
 Novavax NVAX | 103,429,000 | -54.30% | 🇺🇸 USA |
 Exelixis EXEL | 308,482,000 | 36.31% | 🇺🇸 USA |
 Enzo Biochem ENZ | 50,490,000 | -77.69% | 🇺🇸 USA |